Peter MD Review: A Four-Week Supply Is Not a Month

The short version

Peter MD is a broad men's-health telehealth shop where sermorelin is one line on the shelf, priced at $211.65 for a four-week supply or $585.00 for twelve weeks. The catalog runs to 145 products — testosterone, GLP-1s, sildenafil, finasteride, thyroid, lab panels, protein powder and branded hats — and sermorelin sits inside the "Enhance Performance" menu between a B12 shot and thyroid optimization. That is not a criticism on its own. It is the fact that shapes everything else here, and you should buy accordingly.

Three things the price page does not tell you. A four-week supply is not a month, so staying on it costs thirteen purchases a year, not twelve. A $70 provider appointment is added unless you are also buying a testosterone program. And a service fee of about 4% appears only in the cart — $211.65 becomes $220.09, and $585.00 becomes $608.34.

Against that, the single best thing about this company is buried in its Terms. Section 23 is headed "Pharmacy Disclosure" and it names two dispensing pharmacies with street addresses and phone numbers, which most of the 33 providers we track do not do at all. Whoever wrote that section did the reader a real favor. Nobody linked it from the product page.

The price ladder, in full

Read from the company's own pages on 29 August 2026. The marketing page at /sermorelin/ shows two rungs; the shop has a third that the marketing page never mentions.

• •$211.65 — "4-Week Supply", labeled "Best Value". The product page prices the same item as "Original price was: $225.65. Current price is: $211.65."
• •$399.00 — two vials. Two months at $199.50 per vial. Absent from the landing page entirely.
• •$585.00 — "12-Week Supply", labeled "Most Popular", against a stated "Regular price: $634.95" and *"Save $49.95 Today."*

That last rung carries a contradiction worth catching, because the "was" price is what a shopper anchors on. The landing page puts it at $634.95. The product page for the identical item puts it at $685.00. The discount is real either way; how big it looks depends on which page you happened to read.

Each pack is described by vials, not weeks: "1 vial will last 4-6 weeks depending on the dose", and "3 vials will last 12-18 weeks depending on the dose." So the "four-week supply" is a floor rather than a duration. Peter MD publishes no milligram strength for the vial, so you cannot check that or compare cost per milligram against a provider that does.

A four-week supply is not a month

This is the arithmetic that matters, and it is the reason to be careful with any provider that prices in weeks.

A year holds 13.04 four-week periods, not twelve. Stay on the $211.65 pack continuously and you buy it thirteen times: $2,751.45 a year, or about $229 a month — not the $2,539.80 that twelve purchases would suggest. Add the cart's service fee and thirteen real charges of $220.09 come to $2,861.17, about $238 a month. Add the one-off $70 appointment and your first year is roughly $2,931.

The twelve-week pack is genuinely cheaper and still not what a quick division suggests. Divide $585.00 by three and you get $195, which is the figure anyone comparing plans will write down. But twelve weeks is 84 days, and 84 days recurs 4.35 times in a year rather than four: $2,541.96 a year on the sticker, $2,643.38 with the service fee — around $220 a month, against the $2,340 that "$195 × 12" implies. A roughly $300 gap, produced entirely by treating a four-week block as a calendar month.

The error is always in the seller's favor and it is never a lie — it is a division nobody finishes. Our price-sorted list normalizes every figure to the same denominator; our methodology explains how.

Good news in the same area: this is not a subscription. Both sermorelin items are ordinary one-off purchases, the cart shows a single line with no renewal language, and the Auto-Bill Policy limits automatic renewal to products "as described during checkout" — nothing described one here. You re-buy rather than get re-billed, so the numbers above are the cost of staying on it, not charges that arrive regardless.

Two states on the marketing page, seven on the product

Peter MD's sermorelin landing page carries one line about geography, printed twice: "Not available in these states: AL, ID." It appears on that page and on no other page we read.

The three pages that actually sell the product say something different, and they do not agree with each other either:

• •One-month: "NOT AVAILABLE TO THE FOLLOWING STATES: AL, AR, CA, ID, MI, NC."
• •Two-month: "NOT AVAILABLE TO THE FOLLOWING STATES: AL, AR, CA, ID, KY, MI, NC, SC."
• •Three-month: "PRODUCT NOT AVAILABLE to KS, AL, AR, CA, ID, MI, NC."

Take the union and nine states appear on at least one sermorelin page: Alabama, Arkansas, California, Idaho, Kansas, Kentucky, Michigan, North Carolina and South Carolina. Only Alabama and Idaho appear on all four.

The checkout resolves part of this and makes the rest worse. Peter MD's billing address form offers 48 states plus the District of Columbia; Alabama and Idaho are simply not in the list, for any product. So the two-state restriction is a store-wide one, enforced by the address form — it is not specific to sermorelin at all, which is exactly why it is the version that reached the marketing page. The other seven states are the sermorelin-specific exclusions, and Arkansas, California, Kansas, Kentucky, Michigan, North Carolina and South Carolina were all selectable in the cart with a sermorelin pack in it. We did not complete a purchase, so we cannot tell you what happens after payment in those states. We can tell you the form will take your address and your card.

If you live in one of those seven, ask before you pay.

The two pharmacies in the fine print

Terms & Conditions §23, headed "Pharmacy Disclosure", names them outright:

> "Absolute Pharmacy – 16011 N Nebraska Ave #103, Lutz, FL 33549 — (813) 999-2700 > Partell Pharmacy – 5835 S. East Ave, Las Vegas, NV — (702) 791-3800"

Two named pharmacies with verifiable addresses is more disclosure than most of the sellers we track manage, and it is enough to screen them: we searched the FDA's warning-letter index for both names on 29 August 2026 and found nothing, in a run where a telehealth company holding a 2026 letter returned as expected.

What is missing is the classification. No page on this site says 503A or 503B, and the distinction is not cosmetic: a 503A pharmacy is licensed and inspected by a state board, while a 503B outsourcing facility registers with the FDA and works under cGMP. Compounded sermorelin is not an FDA-approved product under either heading, and no compounded drug is reviewed for safety or efficacy before it is dispensed⁶. Section 24 also says prescriptions are "sent electronically to a pharmacy of the patient's choosing," which sits oddly beside a two-pharmacy disclosure; you should assume one of the two named unless someone tells you otherwise.

No individual clinician is named anywhere. Across all fifteen pages we read, there is no physician name, no NPI, no state license number and no medical director. The FAQ says only that "all of our physicians possess the mandatory state medical licenses, controlled substance licenses and individual state DEA licenses required to treat US based patients." Several companies on our ranking publish a name and a number you can check against a state board. This one does not.

Refunds, cancellation, and the pages that disagree

The Refund and Auto-Bill Policy is strict and clearly written: all sales are final once medication is received, replacement only for a defective or damaged item with a photo submitted within 24 hours, and auto-renewals cancelable only by emailing support at least 48 hours before the renewal date — "No cancellations will be accepted less than forty-eight (48) hours before the renewal date." The policy says outright that it will be produced to the payment processor in a chargeback dispute.

The reassurance you actually want is not on that page. It is at the bottom of the checkout: "If a prescription is not approved, the order will be canceled, and a full refund will be issued." That is the right answer to the right question, and it is printed at the last possible moment.

Three more places where two Peter MD pages contradict each other, all read the same day:

• •"No hidden fees" on the About page, against a $70 appointment charge on the product page and a service fee that appears only in the cart.
• •"Unlimited free consultations" on the About page, against "the program purchase does not cover the appointment with the provider unless you are purchasing TRT."
• •The FAQ asks "Can I claim insurance for PeterMD treatment?" twice. Under Customer service the answer is "PeterMD services, products, and medications are not covered by health insurance policies." Under Payment the answer to the identical question begins "Yes!" and describes using insurance for lab work with a $25 processing fee. Both are on /how-it-works/. Our guide to insurance and sermorelin explains why the first answer is the one that holds for the medication.

Cancellation gets the same treatment: the policy page says email support, the FAQ says cancel from the Member Account page. One of those is the operative instruction and the site does not say which.

What the page says sermorelin is

Two claims in Peter MD's own copy are wrong about the drug, and on a page selling it that is worth correcting.

The landing page calls sermorelin "a growth hormone-releasing peptide (GHRP)." It is not. GHRPs are ghrelin-receptor agonists — ipamorelin, hexarelin, GHRP-2 and GHRP-6 — a separate class acting at a separate receptor⁵. Sermorelin is the first 29 amino acids of growth-hormone-releasing hormone and acts at the pituitary's GHRH receptor³, which is the whole basis of the two classes being combined in a stack. We set the difference out in GHRH versus GHRP.

The product pages then say sermorelin "stimulates the hypothalamus, increasing the secretion of Growth Hormone Releasing Hormone." That runs the mechanism backwards. Sermorelin does not make you produce more GHRH; it is GHRH, and it prompts the pituitary to release more of your own growth hormone³ — which is why it is dosed at night and why the best-supported effects are on sleep and the GH/IGF-1 axis rather than the mirror. Nightly GHRH(1-29) raised GH and IGF-1 in healthy older men in a controlled study⁴, while the wider literature on augmenting growth hormone in healthy adults finds small body-composition changes, no functional gain and a real side-effect rate⁷. Our evidence review grades each claim, and the benefit list on these product pages — immune strengthening, faster surgical healing, bone mineralization — goes well past what that evidence supports.

Verdict

Peter MD is a busy men's-health store that also sells sermorelin, and it should be judged as that rather than as a sleep clinic. The 12-week pack at $585.00 is fair money for the category, the two pharmacies named in its Terms are a real disclosure, and the FDA index is clean on every name the company gives.

What it costs you is precision. Budget thirteen purchases a year, not twelve; add roughly 4% at the cart and $70 for the appointment unless you are on a testosterone program; and if you live in one of the seven states the product pages exclude but the checkout still accepts, get that answered in writing first. Then read the full ranking — several companies there publish a named clinician, a compounding class and a single price that does not change between the page and the cart.